Emergence and Persistence of Resistance-Associated Substitutions in HCV GT3 Patients Failing Direct-Acting Antivirals

Background: The hepatitis C virus has a high mutation rate, which results in the emergence of resistance-associated substitutions (RASs). Despite direct-acting antivirals (DAAs) efforts to treat chronically infected HCV genotype 3 (GT3) patients, there are concerns about the emergence and persistenc...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Saima Mushtaq, Asraf Hussain Hashmi, Amjad Khan, Syed Muhammad Asad Raza Kazmi, Sobia Manzoor
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Frontiers Media S.A. 2022-04-01
Cyfres:Frontiers in Pharmacology
Pynciau:
hepatitis C virus
genotype 3
direct-acting antiviral
relapse
resistance-associated substitutions
Mynediad Ar-lein:https://www.frontiersin.org/articles/10.3389/fphar.2022.894460/full
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg